June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
The anti-fibrotic Halofuginone regulates the expression of Egr-1 in human corneal fibroblasts
Author Affiliations & Notes
  • Ching Yuan
    Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN
  • Megan Twite
    Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN
  • Elizabeth Nelson
    Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN
  • Footnotes
    Commercial Relationships Ching Yuan, None; Megan Twite, None; Elizabeth Nelson, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5246. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ching Yuan, Megan Twite, Elizabeth Nelson; The anti-fibrotic Halofuginone regulates the expression of Egr-1 in human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5246.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Transcriptional factor early growth response-1 (Egr-1) plays important roles in the pathogenesis of fibrosis. Unlike regulation of other transcription factors, which rely on post-translational modifications (i.e., phosphorylation), regulation of Egr-1 signaling is mediated via its biosynthesis and by interaction with regulatory molecules, such as Nab2. We have previously demonstrated the anti-fibrotic efficacy of halofuginone, a compound derived from herbal alkaloids, in cultured human corneal fibroblasts (Nelson et al., Molecular Vision 2012). In the current study, we identified Egr-1 as the downstream effector of halofuginone.

Methods: Human corneal fibroblasts were extracted from donor corneas provided by Minnesota Lions Eye Bank. To delineate the profibrotic roles of Egr-1 in the corneal fibroblasts, Egr-1 transgene as well as an Egr-1-specific DNA enzyme (ED5) were transfected into cells to either constitutively overexpress or suppress Egr-1 expression. Human corneal fibroblast cells were treated with halofuginone and TGFβ-1 to investigate the expression profile of Egr-1, Nab2, and other fibrosis-related genes using qRT-PCR, Western blot, and immunohistochemistry. The transactivation of collagen type I gene by Egr-1 after halofuginone treatment was evaluated using (1) a reporter plasmid containing the luciferase gene driven by the collagen type I promoter, and (2) promoter-transcription factor pull down assay.

Results: Our results showed that overexpression or knockdown of Egr-1 modulated the expression of fibrotic markers, including alpha smooth muscle actin, and fibronectin in human corneal fibroblasts. Egr-1 also bound directly to the collagen type I promoter and facilitated the production of collagen. Halofuginone significantly reduced the expression of Egr-1 in a dose- and time-dependent manner according to the Western blot and qRT-PCR results. Immunostaining experiments revealed that the fast nuclear translocation of Egr-1 induced by TGFβ-1 was also abolished with halofuginone treatment.

Conclusions: The current study confirms the profibrotic role of Egr-1 in human corneal fibroblasts. Egr-1 signaling is among the divergent fibrotic pathways affected by halofuginone, and may serve as a promising target for anti-fibrotic applications in the cornea.

Keywords: 484 cornea: stroma and keratocytes • 765 wound healing  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×